Schizophrenia can be broken down into brain structure and gut health subtypes, which can be used for targeted treatment.

This leads to different subtypes of GBS called: acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN), respectively. Lingering questions.

However, there are many different subtypes of GBS, so symptoms can vary; for some, the first signs are vision changes or ...

The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy ...

The RRT members visited the homes of 62 GBS patients to gather information about their water sources. The water samples collected from the homes of 26 GBS patients were found to be without any ...

Patients with Guillain- Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.

Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder where the immune system attacks peripheral nerves, causing weakness, tingling, and sometimes paralysis. It often follows infections ...

Overall, the work of the research team offers novel insights into our understanding of GBS, opening avenues for further investigations on larger patient groups to decipher immune mechanisms in ...

GBS often starts with mild tingling or weakness in the hands and feet. However, symptoms can rapidly worsen, progressing to severe muscle weakness and, in some cases, paralysis.

For example, while it is thought that there is a small increased risk of developing GBS after flu vaccination — among 1 million people who get vaccinated, there may be one or two more cases than ...

The study highlights that 53% of GBS leaders rank productivity improvement as their top priority for 2024, and cite limited access to reliable data as a key barrier.